|
[1]
|
Hendriks, R.W., Yuvaraj, S. and Kil, L.P. (2014) Targeting Bruton’s Tyrosine Kinase in B Cell Malignancies. Nature Reviews Cancer, 14, 219-232. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Rickert, R.C. (2013) New Insights into Pre-BCR and BCR Signalling with Relevance to B Cell Malignancies. Nature Reviews Immunology, 13, 578-591. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Kawakami, Y., Kitaura, J., Hata, D., et al. (1999) Function of Bruton’s Tyro-sine Kinase in Mast and B Cells. Journal of Leukocyte Biology, 65, 286-290. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Spaargaren, M., de Rooij, M.F., Kater, A.P., et al. (2015) BTK Inhibitors in Chronic Lymphocytic Leukemia: A Glimpse to the Future. Oncogene, 34, 2426-2436. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Wang, Y., Zhang, L.L., Champlin, R.E., et al. (2015) Targeting Bruton’s Tyrosine Kinase with Ibrutinib in B-Cell Malignancies. Clinical Pharmacology and Therapeutics, 97, 455-468. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Michael, B.J., Mcfarland, J.M., Paavilainen, V.O., Angelina, B., Danny, T., Phan, V.T., Sergei, R., David, F., Jin, S. and Vaishali, P. (2015) Prolonged and Tunable Residence Time Using Reversi-ble Covalent Kinase Inhibitors. Nature Chemical Biology, 11, 525-531. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Jain, M., Chatterjee, A., Mohapatra, J., Bandhyopadhyay, D., Ghosh-dostidar, K., Bhatnagar, U., Patel, H., Bahekar, R., Ramanathan, V. and Patel, P. (2015) 326 A novel Bruton’s Tyrosine Kinase (BTK) Inhibitor with Anticancer and Anti Inflammatory Activities. European Journal of Cancer, 51, S63. [Google Scholar] [CrossRef]
|
|
[8]
|
Molina-Cerrillo, J., Alonso-Gordoa, T., Gajate, P. and Grande, E. (2017) Bruton’s Tyrosine Kinase (BTK) as a Promising Target in Solid Tumors. Cancer Treatment Reviews, 58, 41. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
De, C.S., Kurian, J., Dufresne, C., Mittermaier, A.K. and Moitessier, N. (2017) Covalent in Hibitors Design and Discovery. European Journal of Medicinal Chemistry, 138, 96-114. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Kollman, P.A., Massova, I., Reyes, C., Kuhn, B., Huo, S., Chong, L., Lee, M., Lee, T., Duan, Y., Wang, W., Donini, O., Cieplak, P., Srinivasan, J., Case, D.A. and Cheatham, T.E. (2000) Calculating Structures and Free Energies of Complex Molecules: Combining Molecular Mechanics and Con-tinuum Models. Accounts of Chemical Research, 33, 889-897. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Brown, S.P. and Muchmore, S.W. (2006) High-Throughput Calculation of Protein-Ligand Binding Affinities: Modification and Ad-aptation of the MM-PBSA Protocol to Enterprise Grid Computing. Journal of Chemical Information and Modeling, 46, 999-1005. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Bender, A.T. (2017) Ability of Bruton’s Tyrosine Kinase Inhibi-tors to Sequester Y551 and Prevent Phosphorylation Determines Potency for Inhibition of Fc Receptor but not B-Cell Receptor Signaling. Molecular Pharmacology, 91, 208-219. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Ryckaert, J.P., Ciccotti, G. and Berendsen, H.J.C. (1977) Numerical Integration of the Cartesian Equations of Motion of a System with Constraints: Molecular Dynamics of n-Alkanes. Journal of Computational Physics, 23, 327-341. [Google Scholar] [CrossRef]
|
|
[14]
|
Darden, T., York, D. and Pedersen, L. (1993) Particle Mesh Ewald: An N⋅log(N) Method for Ewald Sums in Large Systems. The Journal of Chemical Physics, 98, 10089-10092. [Google Scholar] [CrossRef]
|
|
[15]
|
侯廷军, 李有勇. MM/PBSA和MM/GBSA对蛋白-配体自由能计算精度的评估研究[C]//中国化学会. 中国化学会第28届学术年会第14分会场摘要集. 成都: 四川大学出版社, 2012: 01-05.
|